Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 2 9Phase 1/2 5Phase 3 4Phase 1 4Phase 4 1Phase 2/3 1

Status

Completed 51Active not recruiting 24Unknown 19Terminated 17Recruiting 16Withdrawn 8Not yet recruiting 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 41Carcinoma, Non-Small-Cell Lung 28Colorectal Neoplasms 16Neoplasms 13Nasopharyngeal Carcinoma 11Lung Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Stomach Neoplasms 9Prostatic Neoplasms 9Ovarian Neoplasms 8Multiple Myeloma 8Squamous Cell Carcinoma of Head and Neck 7Small Cell Lung Carcinoma 7Rectal Neoplasms 7Esophageal Neoplasms 7Triple Negative Breast Neoplasms 6Pancreatic Neoplasms 6Non-Muscle Invasive Bladder Neoplasms 6Uterine Cervical Neoplasms 5Recurrence 5Neoplasm Metastasis 5Glioblastoma 5Colonic Neoplasms 5Brain Neoplasms 5Adenocarcinoma 5Urinary Bladder Neoplasms 4Polycystic Ovary Syndrome 4Lymphoma, Follicular 4Fallopian Tube Neoplasms 4

Interventions

trilaciclib 1tislelizumab 1Gemcitabine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × Urinary Bladder Neoplasms × Clear all
NCT07480356 2026-03-18

ADVANCED-3

Protara Therapeutics

Phase 3 Not yet recruiting
284 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

NCT07464145 2026-03-11

RESCUE

Relmada Therapeutics, Inc.

Phase 3 Not yet recruiting
393 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

NCT06364904 2025-02-21

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Not yet recruiting
210 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05810623 2023-04-12

MINERVA

Medical University of Vienna

Phase 3 Not yet recruiting
394 enrolled
Genitourinary

Urinary Bladder Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡